why choose us

First received: July 26, 2022

Clinical Trial: IL13 Signaling in Allergic Asthma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Asthma, Allergic

Study Type: OBSERVATIONAL


Official Title: The Effects of Dupilumab on Asthma Outcomes and IL-13R?2 Signaling in Airway Epithelial Cells in Allergic Asthma With Comorbid BMI ? 30

Brief Summary: This study will investigate the role of dupilumab in the treatment of asthma with comorbid obesity.It is hypothesized that in airway epithelial cells, unique transcriptomic and proteomic expression patterns distinguish allergic and non-allergic patients with asthma and obesity and drive significant differential responses to dupilumab.It is further hypothesized that dupilumab will increase interleukin-13 receptor alpha 2 (IL-13R?2) levels and/or signaling activity on airway epithelial cells isolated from…

Read more